INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. – CAPR

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capricor and certain of its officers and/or […]

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in XPLR Infrastructure, LP (f/k/a NextEra Energy Partners, LP) of Class Action Lawsuit and Upcoming Deadlines – XIFR

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against XPLR Infrastructure, LP ("XPLR" or the "Company") (NYSE:XIFR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – RCKT

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ:RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Deepfake AI Market is expected to generate a revenue of USD 41.36 Billion by 2032, Globally, at 35.7% CAGR: Verified Market Research®

TheDeepfake AI Market presents compelling growth opportunities, especially in regions like North America where technological maturity and regulatory evolution coexist. While drivers such as generative AI advancements and personalized content demand fuel adoption, market entry strategies must address risks like misinformation and legal ambiguity. B2B players should focus on ethical use cases, invest in detection

Update Hydrolyzed Collagen Market Forecast at CAGR 5.5% Through 2031: Highlight Rising Demand for Functional Foods and Collagen Supplements | The Insight Partners

According to a new research report from The Insight Partners, the global hydrolyzed collagen market is observing significant growth owing to the wide application scope and strategic initiatives by key market players. https://mma.prnewswire.com/media/1586348/5449703/The_Insight_Partners_Logo.jpg The hydrolyzed collagen market value is expected to reach US$1.91 billion by 2031 from US$1.32 billion in 2024; it is expected to

Trailmark Fund Solutions: A Trusted Partner for Registered Funds

Trailmark Fund Solutions (“Trailmark”) today introduced the launch of its new brand identity, reinforcing its commitment to delivering innovative and boutique fund administration, fund accounting, and transfer agency solutions to asset managers across the United States. While the name is new, the company is not-currently servicing over $10 billion of assets under administration, Trailmark brings

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines – VSTS

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation ("Vestis" or the "Company") (NYSE:VSTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz Law Firm Announces the Filing of a Class Action Against Flywire Corporation and Certain Officers – FLYW

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Flywire Corporation ("Flywire" or the "Company") (NASDAQ:FLYW) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-04110,

Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc.â?¯and Certain Officers – ANRO

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE:ANRO) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-06105,

Scroll to Top